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Cationic tetranuclear arene ruthenium complexes of the ge-
neral formula [Ru4(p-cymene)4(NN)2(dhnq)2]4+ comprising
rectangular structures are obtained in methanol from the re-
action of the dinuclear arene ruthenium precursor [Ru2(p-cy-
mene)2(dhnq)2Cl2] (dhnq = 5,8-dihydroxy-1,4-naphthoqui-
nonato) with pyrazine or bipyridine linkers [NN = pyrazine,
1; 4,4-bipyridine, 2; 1,2-bis(4-pyridyl)ethylene, 3] in the
presence of AgCF3SO3. All complexes 1–3, isolated in good
yield as triflate salts, have been characterised by NMR and
IR spectroscopy. The interaction of these rectangular com-
plexes with pyrene as a guest molecule has been studied in
solution by various NMR techniques (1D, DOSY, ROESY). In
Introduction
Arene ruthenium(II) and cyclopentadienyl rhodium(III)
or iridium(III) half-sandwich complexes have received con-
siderable attention over the last decade, especially as build-
ing blocks in supramolecular chemistry.[1] Their ability to
generate a pre-organised arrangement with appropriate
multidentate bridging ligands and connectors has allowed
the controlled formation of various supramolecular con-
structions. Indeed, we have used, as well as others, arene
ruthenium complexes as building blocks for the assembly
of a series of cationic metalla-rectangles containing
OOOO or ONNO bridging ligands (OOOO = oxal-
ato, 2,5-dihydroxy-1,4-benzoquinonato, 2,5-dichloro-1,4-
benzoquinonato, 6,11-dihydroxy-5,12-naphthacenedionato;
ONNO = oxonato, 2,5-diarylamino-1,4-benzoquinonato)
and polypyridyl ligands [NN = pyrazine, 4,4-bipyridine,
4,7-phenanthroline, 1,2-bis(4-pyridyl)ethylene, 2,5-bis(4-
pyridyl)-1,3,5-oxadiazolato] as connectors.[2] The oxalato
derivatives[Ru4(p-cymene)4(bpe)2(oxalato)2]4+,[3][Rh4(Cp*)4-
(bpe)2(oxalato)2]4+ and [Ir4(Cp*)4(bpe)2(oxalato)2]4+ con-
nected with 1,2-bis(4-pyridyl)ethylene (bpe)[4] have shown
[2+2] photochemical cycloaddition in solution as well as in
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[D3]acetonitrile, the pyrazine-containing metalla-rectangle 1
shows no meaningful interactions with pyrene. On the other
hand, the 4,4-bipyridine- and 1,2-bis(4-pyridyl)ethylene-
containing metalla-rectangles 2 and 3 clearly interact with
pyrene in [D3]acetonitrile. DOSY measurements suggest
that, in the case of [Ru4(p-cymene)4(4,4-bipyridine)2-
(dhnq)2]4+ (2), the interactions occur on the outside of the
rectangular assembly, while in the case of [Ru4(p-cymene)
4{1,2-bis(4-pyridyl)ethylene}2(dhnq)2]4+ (3), the pyrene mole-
cule is found inside the hydrophobic cavity of the metalla-
rectangle, thus giving rise to a host-guest system.
the solid state, while the [M4(Cp*)4(pyrazine)2(6,11-dihy-
droxy-5,12-naphthacene-dionato)2]4+ (M = Rh, Ir)[5] have
been found to encapsulate CH2Cl2 or ClCH2CH2Cl molec-
ules under single-crystal-to-single-crystal transformation
conditions. On the other hand, the [Ru4(p-cymene)4(4,4-
bipyridine)2(oxonato)2]4+ and [Ru4(p-cymene)4(4,7-phen-
anthroline)2(oxonato)2]4+ metalla-rectangles[6] as well as a
series of p-cymene and hexamethylbenzene ruthenium
metalla-rectangles of the general formula [Ru4(arene)4-
(NN)2(OOOO)2]4+ {OOOO = 2,5-dihydroxy-1,4-
benzoquinonato, 2,5-dichloro-1,4-benzoquinonato; NN =
pyrazine, 4,4-bipyridine, 1,2-bis(4-pyridyl)ethylene}[7] have
been found to be cytotoxic against cancer cell lines. Herein
we report the synthesis and characterisation of a new series
of tetranuclear cations incorporating p-cymene ruthenium
building blocks, bridged by 5,8-dihydroxy-1,4-naphtho-
quinonato (dhnq) ligands, and connected by pyrazine, 4,4-bi-
Figure 1. Structural representations of the cationic metalla-rect-
angles 1–3.
Published in European Journal of Inorganic Chemistry 5, 725-728, 2010
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pyridine or 1,2-bis(4-pyridyl)ethylene bidentate connectors,
see Figure 1. Their ability to interact with pyrene in solu-
tion has been studied by NMR experiments.
Results and Discussion
Addition of AgCF3SO3 to the dinuclear complex [Ru2(p-
cymene)2(dhnq)Cl2][8] in the presence of NN bidentate li-
gands {pyrazine, 4,4-bipyridine or 1,2-bis(4-pyridyl)-
ethylene} leads to the formation of the tetranuclear cations
[Ru4(p-cymene)4(NN)2(dhnq)2]4+ {NN = pyrazine, 1;
4,4-bipyridine, 2; 1,2-bis(4-pyridyl)ethylene, 3} in good
yield (≈ 75%). These rectangular cations are isolated as
their triflate salts [1][CF3SO3]4, [2][CF3SO3]4 and [3]-
[CF3SO3]4, respectively.
The 1H NMR spectrum of 1 displays a singlet due to the
pyrazine protons. As in free pyrazine, where the proton sig-
nal is found at δ = 8.57 in [D3]acetonitrile, the correspond-
ing signal of 1 appears at δ = 8.56 ppm. The 1H NMR spec-
trum of 2 shows two doublets due to the 4,4-bipyridine
protons with an upfield shift of 0.24 ppm for the doublet
(Hα) found at δ = 8.67 ppm in the free 4,4-bipyridine in
[D3]acetonitrile, the doublet (Hβ) at δ = 7.69 ppm being not
affected by the coordination to the arene ruthenium units.
The same upfield shift is observed with the protons of the
1,2-bis(4-pyridyl)ethylene connector in complex 3, see Fig-
ure 2. Upon formation of the cationic tetranuclear metalla-
rectangles, the methyl and isopropyl signals of the p-cymene
ligands in 1–3 remain almost unchanged as compared to
complex [Ru2(p-cymene)2(dhnq)Cl2], while the aromatic
protons of the p-cymene ligands are slightly shifted upfield.
However, the proton signal of the 5,8-dihydroxy-1,4-naph-
thoquinonato bridging ligands in all metalla-rectangles 1–3
is shifted downfield as compared to the parent complex
[Ru2(p-cymene)2(dhnq)Cl2].[8]
The cavity size of the different metalla-rectangles was es-
timated from molecular modelling and from analogous
structures incorporating the same bridging and connecting
ligands. The pyrazine cation 1 possesses a cavity of about
about 8.47.0 Å2 (Ru–Ru distances), while the cavity size
of the bpy and bpe metalla-rectangles 2 and 3 are expected
to be approximately 8.411.2 and 8.413.6 Å2, respec-
tively, see Figure 1. Therefore, considering the size of the
hydrophobic cavity and the presence of aromatic surfaces
in the multiple components of 1–3, we decided to study the
host-guest properties of these metalla-rectangles in the pres-
ence of pyrene, since pyrene molecule was recently found to
interact strongly in the hydrophobic cavity of the metalla-
prisms [Ru6(p-cymene)6(tpt)2(dhnq)3]6+ {tpt = 2,4,6-tris(4-
pyridyl)-1,3,5-triazine}[8] and [Ru6(p-cymene)6(tpt)2-
(dhbq)3]6+ (dhbq = 2,5-dihydroxy-1,4-benzoquinonato).[9]
Upon gradual addition of pyrene (0.2–20.0 equiv.) to a
CD3CN solution of metalla-rectangles 1, 2 and 3 (4.0 m),
the 1H NMR spectra of 2 and 3 show displacements of the
chemical shifts of some of the protons of the host and of
the guest, while in the case of 1 no chemical shift changes
are observed, see Figure 3. In 2, the Hβ protons of the pyr-
Figure 2. 1H NMR spectra (400 MHz, CD3CN) of free pyrazine,
4,4-bipyridine and 1,2-bis(4-pyridyl)ethylene as well as metalla-
rectangles 1–3.
idyl groups are the most affected by the presence of pyrene
molecules in solution. Moreover, in 3, all protons of the
NN bidentate ligands as well as the pyrenyl protons are
shifted. This suggests different types of interactions be-
tween metalla-rectangles 2 and 3 with pyrene in solution.
Figure 3. 1H NMR titrations of pyrene in a CD3CN solution of
[2][CF3SO3]4 (left, 4.0 m, 25 °C) and of [3][CF3SO3]4 (right,
4.0 m, 25 °C).
To gain further insight on the nature of the interactions
involved between pyrene and metalla-rectangles 2 and 3, we
performed a series of DOSY measurements.[10] Diffusion-
ordered (DOSY) NMR spectroscopy is a valuable tool for
investigating large molecules in solution.[11] It is clear from
the DOSY spectra of pyrene and 2 (Figure 4) that both
2
compounds keep the same diffusion constant even when
mixed together. Therefore, the chemical shifts observed for
the host and the guest are attributed to outer interactions.
Figure 4. DOSY 1H NMR spectra of pyrene, [2][CF3SO3]4 and of
additional amounts of pyrene (1 to 3 equiv.) to a 4.0 m solution
of [2][CF3SO3]4.
However, the case of 3 in the interaction with pyrene is
totally different. The DOSY spectra show that for a 1:1
mixture of pyrene and [3][CF3SO3]4 both diffusion coeffi-
cients are almost equivalent at about 6.310–10 m2 s–1 (see
Figure 5). Consequently, the pyrene appears to be located
in the hydrophobic cavity of 3, which is in accordance with
the strong chemical shift observed for both species in the
1H NMR spectra (Figure 3).
Figure 5. DOSY 1H NMR spectra of pyrene, [3][CF3SO3]4 and of
additional amounts of pyrene (1 to 3 equiv.) to a 4.0 m solution
of [3][CF3SO3]4.
To confirm the presence of a pyrene molecule in the cav-
ity of metalla-rectangle 3 in solution, one-dimensional
ROESY experiments were performed in [D3]acetonitrile.
The ROESY experiments were recorded as described pre-
viously.[12] As shown in Figure 6, intense cross-peaks are
observed between the protons of the pyrene molecule and
the protons of the cationic metalla-rectangle 3 in close
proximity, especially those of the connecting 1,2-bis(4-pyr-
idyl)ethylene ligands (Hα, Hβ and HC=C). Therefore, we can
conclude that in the case of 3 the pyrene molecule is prefer-
ably positioned in the hydrophobic cavity of the metalla-
rectangle giving rise to a host-guest system.
Figure 6. One-dimensional 1H ROESY spectra (400 MHz, CD3CN,
25 °C) of pyrene and 3 focusing on the 1,2-bis(4-pyridyl)ethylene
protons Hα (A), Hβ (B) and HC=C (C).
Conclusions
The present study reveals that rectangular-shaped tetra-
nuclear arene ruthenium complexes containing OOOO-
bridges and NN-linkers can be designed to measure by
choosing the dimensions of the NN-dipyridyl-type ligands
in order to accommodate a pyrene guest molecule inside
their cavity. In contrast to the carceplex system formed by
the metalla-prism [Ru6(p-cymene)6(tpt)2(dhbq)3]6+ with
pyrene, [pyreneRu6(p-cymene)6(tpt)2(dhbq)3]6+, where the
guest is permanently encapsulated,[9] the host-guest system
formed by metalla-rectangle 3 with pyrene is dynamic and
only observed in solution.
Experimental Section
General: [Ru2(p-cymene)2(dhnq)Cl2] was prepared according to
publish methods.[8] All other reagents were commercially available
(Sigma–Aldrich) and used as received. The 1H, 13C{1H}, 1H DOSY
and 1H ROESY NMR spectra were recorded on a Bruker Av-
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ance II 400 spectrometer using the residual protonated solvent as
internal standard. Infrared spectra were recorded as KBr pellets
on a Perkin–Elmer FTIR 1720 X spectrometer. UV/Vis absorption
spectra were recorded on an Uvikon 930 spectrophotometer using
precision cells made of quartz (1 cm). Elemental analyses were per-
formed by the Laboratory of Pharmaceutical Chemistry, University
of Geneva (Switzerland).
Synthesis of Metalla-Rectangles [1–3][CF3SO3]4: A mixture of
[Ru2(p-cymene)2(dhnq)Cl2] (0.21 mmol), two equivalents of
AgCF3SO3 (0.43 mmol) and one equivalent of the corresponding
NN ligand (0.21 mmol) in methanol (40 mL) was stirred at 60 °C
for 24 h and then filtered to remove AgCl. The solvent was re-
moved under vacuum and the residue was taken up in dichloro-
methane (3 mL) and diethyl ether was added to precipitate the
product as green or blue solids.
[1][CF3SO3]4: Yield 191 mg, (85%). UV/Vis [1.010–5 , (CH3)2-
CO]: λmax = 306 nm (ε = 3.60105 –1 cm–1), λmax = 434 nm (ε =
0.27105 –1 cm–1), λmax = 633 nm (ε = 0.12105 –1 cm–1), λmax
= 692 nm (ε = 0.12105 –1 cm–1). IR (KBr): ν˜ = 3066 (w,
CHcymene), 1538 (s, C=O), 1263 (s, CF3) cm–1. 1H NMR (400 MHz,
CD3CN): δ = 8.56 (s, 8 H, Hpyrazine), 7.17 (s, 8 H, Hdhnq), 5.77 (d,
3JH,H = 5.7 Hz, 8 H, Hcymene), 5.72 (d, 8 H, Hcymene), 2.85 [sept,
3JH,H = 2.8 Hz, 2 H, CH(CH3)2], 2.14 (s, 12 H, CH3), 1.47 [d, 24
H, CH(CH3)2] ppm. 13C{1H} NMR (100 MHz, CD3CN): δ = 171.0
(CO), 148.8 (CHpyrazine), 137.4 (CHdhnq), 111.5 (Cdhnq), 105.3
(Ccymene), 100.0 (Ccymene), 84.1 (CHcymene), 84.0 (CHcymene), 30.8
[CH(CH3)2], 21.9 [CH(CH3)2], 16.8 (CH3) ppm.
C72H72F12N4O20Ru4S4 (2073.8): calcd. C 41.70, H 3.49, N 2.70;
found C 41.02, H 3.16, N 2.38.
[2][CF3SO3]4: Yield 180 mg, (77%). UV/Vis [1.010–5 , (CH3)2-
CO]: λmax = 306 nm (ε = 3.58105 –1 cm–1), λmax = 434 nm (ε =
0.25105 –1 cm–1), λmax = 633 nm (ε = 0.11105 –1 cm–1), λmax
= 692 nm (ε = 0.11105 –1 cm–1). IR (KBr): ν˜ = 3070 (w,
CHcymene), 1536 (s, C=O), 1261 (s, CF3) cm–1. 1H NMR (400 MHz,
CD3CN): δ = 8.43 (d, 3JH,H = 8.1 Hz, 8 H, Hα), 7.69 (d, 8 H, Hβ),
7.17 (s, 8 H, Hdhnq), 5.69 (d, 3JH,H = 5.7 Hz, 8 H, Hcymene), 5.48
(d, 8 H, Hcymene), 2.83 [sept, 3JH,H = 2.8 Hz, 4 H, CH(CH3)2], 2.16
(s, 12 H, CH3), 1.37 [d, 24 H, CH(CH3)2] ppm. 13C{1H} NMR
(100 MHz, CD3CN): δ = 171.9 (CO), 153.9 (CHα), 145.8
(Cbipyridine), 138.4 (CHdhnq), 123.9 (CHβ), 114.8 (Cdhnq), 104.7
(Ccymene), 100.5 (Ccymene), 85.2 (CHcymene), 84.0 (CHcymene), 31.5
[CH(CH3)2], 23.1 [CH(CH3)2], 17.3 (CH3) ppm.
C84H80F12N4O20Ru4S4 (2226.0): calcd. C 45.32, H 3.62, N 2.52;
found C 44.82, H 3.48, N 2.42.
[3][CF3SO3]4: Yield 178 mg, (73%). UV/Vis [1.010–5 , (CH3)2-
CO]: λmax = 314 nm (ε = 3.76105 –1 cm–1), λmax = 438 nm (ε =
0.33105 –1 cm–1), λmax = 608 nm (ε = 0.14105 –1 cm–1), λmax
= 650 nm (ε = 0.13105 –1 cm–1), 713 nm (ε =
0.13105 –1 cm–1). IR (KBr): ν˜ = 3067 (w, CHcymene), 1537 (s,
C=O), 1272 (s, CF3) cm–1. 1H NMR (400 MHz, CD3CN): δ = 8.28
(d, 3JH,H = 8.3 Hz, 8 H, Hα), 7.45 (d, 8 H, Hβ), 7.31 (s, 4 H, HC=C),
7.15 (s, 8 H, Hdhnq), 5.66 (d, 3JH,H = 7.4 Hz, 8 H, Hcymene), 5.46
(d, 8 H, Hcymene), 2.79 [sept, 3JH,H = 2.8 Hz, 4 H, CH(CH3)2], 2.17
(s, 12 H, CH3), 1.29 [d, 24 H, CH(CH3)2] ppm. 13C{1H} NMR
(100 MHz, CD3CN): δ = 171.8 (CO), 153.2 (CHα), 146.9 (Cbpe),
138.3 (CHdhnq), 132.1 (CC=C), 124.2 (CHβ), 112.3 (Cdhnq), 104.5
(Ccymene), 100.2 (Ccymene), 85.1 (CHcymene), 84.0 (CHcymene), 31.4
[CH(CH3)2], 22.3 [CH(CH3)2], 17.3 (CH3) ppm.
C88H84F12N4O20Ru4S4 (2278.0): calcd. C 46.40, H 3.72, N 2.46;
found C 45.59, H 3.32, N 2.60.
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